|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0012240,
umls-concept:C0016360,
umls-concept:C0023413,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0040808,
umls-concept:C0123931,
umls-concept:C0278498,
umls-concept:C0282460,
umls-concept:C0585332,
umls-concept:C1257890
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2004-10-29
|
|
pubmed:abstractText |
To determine the efficacy and safety of a biweekly regimen of leucovorin (LV) plus fluorouracil (FU) alone or in combination with cisplatin or irinotecan in patients with previously untreated metastatic gastric adenocarcinoma and to select the best arm for a phase III study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:ArsèneDominiqueD,
pubmed-author:BedenneLaurentL,
pubmed-author:BonnetainFranckF,
pubmed-author:BouchéOlivierO,
pubmed-author:BuecherBrunoB,
pubmed-author:EtiennePierre LucPL,
pubmed-author:Fédération Francophone de Cancérologie Digestive Group,
pubmed-author:GiovanniniMarcM,
pubmed-author:Guérin-MeyerVéroniqueV,
pubmed-author:KaminskyMarie ChristineMC,
pubmed-author:LledoGérardG,
pubmed-author:MilanChantalC,
pubmed-author:MitryEmmanuelE,
pubmed-author:PaitelJean FrancoisJF,
pubmed-author:RaoulJean LucJL,
pubmed-author:RougierPhilippeP,
pubmed-author:SeitzJean FrançoisJF
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4319-28
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15514373-Adenocarcinoma,
pubmed-meshheading:15514373-Adult,
pubmed-meshheading:15514373-Aged,
pubmed-meshheading:15514373-Analysis of Variance,
pubmed-meshheading:15514373-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15514373-Camptothecin,
pubmed-meshheading:15514373-Cisplatin,
pubmed-meshheading:15514373-Female,
pubmed-meshheading:15514373-Fluorouracil,
pubmed-meshheading:15514373-France,
pubmed-meshheading:15514373-Humans,
pubmed-meshheading:15514373-Infusions, Intravenous,
pubmed-meshheading:15514373-Leucovorin,
pubmed-meshheading:15514373-Male,
pubmed-meshheading:15514373-Middle Aged,
pubmed-meshheading:15514373-Quality of Life,
pubmed-meshheading:15514373-Stomach Neoplasms,
pubmed-meshheading:15514373-Survival Analysis,
pubmed-meshheading:15514373-Survival Rate,
pubmed-meshheading:15514373-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803.
|
|
pubmed:affiliation |
Centre Hospitalier Universitaire de Reims, Rims, France. obouche@chu-reims.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
